StockData
Gilead Sciences, Inc. logo

Gilead Sciences, Inc. (GILD) operating KPIs

GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.68+5.07 (+3.06%)

Close on Oct 30, 2026Market cap $211.64BP/E –Yield 1.85%

Gilead Sciences total Kite Cell Therapy Product Sales ($M) ($M)

Form 10-Q / 10-K Disaggregated Revenue Note & Form 8-K Product Sales Summary

QuarterlyAnnual
Latest, Q2 2026
417
Period ended Jun 30, 2026
Change on a year earlier
-14.0%
485 in Q2 2025
History
27 quarters
Since Q4 2019
Sources
22
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTotal Kite Cell Therapy Product Sales ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026417-14.0%Form 10-Q (filed 2026-08-06) ↗
Q1 2026Mar 31, 2026407-12.3%Form 10-Q (filed 2026-05-07) ↗
Q4 2025Dec 31, 2025458-6.1%Form 10-K (filed 2026-02-24) ↗
Q3 2025Sep 30, 2025432-10.9%Form 10-Q (filed 2025-11-07) ↗
Q2 2025Jun 30, 2025485-6.9%Form 10-Q (filed 2026-08-06) ↗
Q1 2025Mar 31, 2025464-3.3%Form 10-Q (filed 2026-05-07) ↗
Q4 2024Dec 31, 2024488+4.5%Form 10-K (filed 2026-02-24) ↗
Q3 2024Sep 30, 2024485-0.2%Form 10-Q (filed 2025-11-07) ↗
Q2 2024Jun 30, 2024521+11.1%Form 10-Q (filed 2025-08-07) ↗
Q1 2024Mar 31, 2024480+7.1%Form 10-Q (filed 2025-05-07) ↗
Q4 2023Dec 31, 2023467+11.5%Form 10-K (filed 2026-02-24) ↗
Q3 2023Sep 30, 2023486+22.1%Form 10-Q (filed 2024-11-12) ↗
Q2 2023Jun 30, 2023469+27.4%Form 10-Q (filed 2024-08-08) ↗
Q1 2023Mar 31, 2023448+63.5%Form 10-Q (filed 2024-05-08) ↗
Q4 2022Dec 31, 2022419+75.3%Form 10-K (filed 2025-02-28) ↗
Q3 2022Sep 30, 2022398+79.3%Form 10-Q (filed 2023-11-07) ↗

Breakdown

What makes up total kite cell therapy product sales ($m)

Cite this data

StockData. (2026). Gilead Sciences Total Kite Cell Therapy Product Sales ($M) ($M), quarterly Q4 2019–Q2 2026 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/onc_cell_therapy

See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.